KarXT for schizophrenia-effectiveness and value: A summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council. | LitMetric

KarXT for schizophrenia-effectiveness and value: A summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council.

Avery McKenna Jeffrey A Tice Melanie D Whittington Abigail C Wright Marina Richardson Finn R Raymond Steven D Pearson David M Rind Foluso Agboola

J Manag Care Spec Pharm

Institute for Clinical and Economic Review, Boston, MA.

Published: June 2024

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11144989	PMC
http://dx.doi.org/10.18553/jmcp.2024.30.6.624	DOI Listing

Publication Analysis

Top Keywords

karxt schizophrenia-effectiveness

4

schizophrenia-effectiveness summary

4

summary institute

4

institute clinical

4

clinical economic

4

economic review's

4

review's england

4

england comparative

4

comparative effectiveness

4

effectiveness public

4

Similar Publications

KarXT for schizophrenia-effectiveness and value: A summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council.

J Manag Care Spec Pharm

June 2024

Institute for Clinical and Economic Review, Boston, MA.

Avery McKenna Jeffrey A Tice Melanie D Whittington Abigail C Wright Marina Richardson

View Article and Find Full Text PDF

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!